We report acute antibody responses to SARS-CoV-2 in 285 patients with COVID-19. Within
19 days after symptom onset, 100% of patients tested positive for antiviral immunoglobulin-G …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel β-coronavirus,
causes severe pneumonia and has spread throughout the globe rapidly. The …

Background We aim to investigate the profile of acute antibody response in COVID-19 patients,
and provide proposals for the usage of antibody test in clinical practice. Methods A multi-…

In December 2019, the corona virus disease 2019 (COVID-19) caused by novel coronavirus
(SARS-CoV-2) emerged in Wuhan, China and rapidly spread worldwide. Few information …

Background: At the end of 2019, a novel coronavirus outbreak causative organism has been
subsequently designated the 2019 novel coronavirus (2019-nCoV). The effectiveness of …

To the Editor: At the end of 2019, an outbreak of novel coronavirus disease 2019 (COVID-19),
caused by 2019-nCov, causing widespread novel coronavirus disease. This outbreak of …

Background Currently, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
spread globally, causing an unprecedented pandemic. However, there is no specific …

Background: At the end of 2019, a novel coronavirus outbreak emerged in Wuhan, China,
and its causative organism has been subsequently designated the 2019 novel coronavirus (…

Background: Long non-coding RNAs (lncRNAs) can remarkably regulate human malignancies
in terms of the development and the progression. Previously, lncRNA LINC00847 (…

Introduction This study explores the preference for daily versus on‐demand pre‐exposure
prophylaxis (PrEP) among men who have sex with men (MSM) in developing countries when …